Improving antitumor outcomes for palliative intratumoral injection therapy through lecithin–chitosan nanoparticles loading paclitaxel–cholesterol complex

Xiao-Yang Chu,1–3,* Wei Huang,2,* Yu-Li Wang,1 Ling-Wei Meng,2 Li-Qing Chen,2 Ming-Ji Jin,2 Lu Chen,1 Chun-Hong Gao,1 Cheng Ge,3 Zhong-Gao Gao,2 Chun-Sheng Gao11State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing 100850,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Chu XY, Huang W, Wang YL, Meng LW, Chen LQ, Jin MJ, Chen L, Gao CH, Ge C, Gao ZG, Gao CS
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2019
Materias:
Acceso en línea:https://doaj.org/article/028c8e36302d466a8f59f630d8cab24e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:028c8e36302d466a8f59f630d8cab24e
record_format dspace
spelling oai:doaj.org-article:028c8e36302d466a8f59f630d8cab24e2021-12-02T06:27:58ZImproving antitumor outcomes for palliative intratumoral injection therapy through lecithin–chitosan nanoparticles loading paclitaxel–cholesterol complex1178-2013https://doaj.org/article/028c8e36302d466a8f59f630d8cab24e2019-01-01T00:00:00Zhttps://www.dovepress.com/improving-antitumor-outcomes-for-palliative-intratumoral-injection-the-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Xiao-Yang Chu,1–3,* Wei Huang,2,* Yu-Li Wang,1 Ling-Wei Meng,2 Li-Qing Chen,2 Ming-Ji Jin,2 Lu Chen,1 Chun-Hong Gao,1 Cheng Ge,3 Zhong-Gao Gao,2 Chun-Sheng Gao11State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, P.R. China; 2State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Department of Pharmaceutics, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, P.R. China; 3Department of Stomatology, The 5th Medical Center of Chinese PLA General Hospital, Beijing 100071, P.R. China *These authors contributed equally to this workBackground: Intratumoral injection is a palliative treatment that aims at further improvement in the survival and quality of life of patients with advanced or recurrent carcinomas, or cancer patients with severe comorbidities or those with a poor performance status.Methods: In this study, a solvent-injection method was used to prepare paclitaxel–cholesterol complex-loaded lecithin–chitosan nanoparticles (PTX-CH-loaded LCS_NPs) for intratumoral injection therapy, and the physicochemical properties of NPs were well characterized.Results: The particle size and zeta potential of PTX-CH-loaded LCS_NPs were 142.83±0.25 nm and 13.50±0.20 mV, respectively. Release behavior of PTX from PTX-CH-loaded LCS_NPs showed a pH-sensitive pattern. The result of cell uptake assay showed that PTX-CH-loaded LCS_NPs could effectively enter cells via the energy-dependent caveolae-mediated endocytosis and macropinocytosis in company with the Golgi apparatus. Meanwhile, PTX-CH-loaded LCS_NPs had a better ability to induce cell apoptosis than PTX solution. The in vivo antitumor results suggested that PTX-CH-loaded LCS_NPs effectively inhibited mouse mammary cancer growth and metastasis to distant organs and significantly improved the survival rate of tumor-bearing mice by intratumoral administration.Conclusion: In general, our study demonstrated that PTX-CH-loaded LCS_NPs used for palliative treatment by intratumoral injection showed improved safety and antitumor efficacy, which provided an alternative approach in the field of palliative chemotherapy. Keywords: lecithin, chitosan, paclitaxel, nanoparticles, pH responsive, palliative chemotherapy, intratumoral injectionChu XYHuang WWang YLMeng LWChen LQJin MJChen LGao CHGe CGao ZGGao CSDove Medical PressarticlelecithinchitosanpaclitaxelnanoparticlespH responsivepalliative chemotherapyintratumoral injectionMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 14, Pp 689-705 (2019)
institution DOAJ
collection DOAJ
language EN
topic lecithin
chitosan
paclitaxel
nanoparticles
pH responsive
palliative chemotherapy
intratumoral injection
Medicine (General)
R5-920
spellingShingle lecithin
chitosan
paclitaxel
nanoparticles
pH responsive
palliative chemotherapy
intratumoral injection
Medicine (General)
R5-920
Chu XY
Huang W
Wang YL
Meng LW
Chen LQ
Jin MJ
Chen L
Gao CH
Ge C
Gao ZG
Gao CS
Improving antitumor outcomes for palliative intratumoral injection therapy through lecithin–chitosan nanoparticles loading paclitaxel–cholesterol complex
description Xiao-Yang Chu,1–3,* Wei Huang,2,* Yu-Li Wang,1 Ling-Wei Meng,2 Li-Qing Chen,2 Ming-Ji Jin,2 Lu Chen,1 Chun-Hong Gao,1 Cheng Ge,3 Zhong-Gao Gao,2 Chun-Sheng Gao11State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, P.R. China; 2State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Department of Pharmaceutics, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, P.R. China; 3Department of Stomatology, The 5th Medical Center of Chinese PLA General Hospital, Beijing 100071, P.R. China *These authors contributed equally to this workBackground: Intratumoral injection is a palliative treatment that aims at further improvement in the survival and quality of life of patients with advanced or recurrent carcinomas, or cancer patients with severe comorbidities or those with a poor performance status.Methods: In this study, a solvent-injection method was used to prepare paclitaxel–cholesterol complex-loaded lecithin–chitosan nanoparticles (PTX-CH-loaded LCS_NPs) for intratumoral injection therapy, and the physicochemical properties of NPs were well characterized.Results: The particle size and zeta potential of PTX-CH-loaded LCS_NPs were 142.83±0.25 nm and 13.50±0.20 mV, respectively. Release behavior of PTX from PTX-CH-loaded LCS_NPs showed a pH-sensitive pattern. The result of cell uptake assay showed that PTX-CH-loaded LCS_NPs could effectively enter cells via the energy-dependent caveolae-mediated endocytosis and macropinocytosis in company with the Golgi apparatus. Meanwhile, PTX-CH-loaded LCS_NPs had a better ability to induce cell apoptosis than PTX solution. The in vivo antitumor results suggested that PTX-CH-loaded LCS_NPs effectively inhibited mouse mammary cancer growth and metastasis to distant organs and significantly improved the survival rate of tumor-bearing mice by intratumoral administration.Conclusion: In general, our study demonstrated that PTX-CH-loaded LCS_NPs used for palliative treatment by intratumoral injection showed improved safety and antitumor efficacy, which provided an alternative approach in the field of palliative chemotherapy. Keywords: lecithin, chitosan, paclitaxel, nanoparticles, pH responsive, palliative chemotherapy, intratumoral injection
format article
author Chu XY
Huang W
Wang YL
Meng LW
Chen LQ
Jin MJ
Chen L
Gao CH
Ge C
Gao ZG
Gao CS
author_facet Chu XY
Huang W
Wang YL
Meng LW
Chen LQ
Jin MJ
Chen L
Gao CH
Ge C
Gao ZG
Gao CS
author_sort Chu XY
title Improving antitumor outcomes for palliative intratumoral injection therapy through lecithin–chitosan nanoparticles loading paclitaxel–cholesterol complex
title_short Improving antitumor outcomes for palliative intratumoral injection therapy through lecithin–chitosan nanoparticles loading paclitaxel–cholesterol complex
title_full Improving antitumor outcomes for palliative intratumoral injection therapy through lecithin–chitosan nanoparticles loading paclitaxel–cholesterol complex
title_fullStr Improving antitumor outcomes for palliative intratumoral injection therapy through lecithin–chitosan nanoparticles loading paclitaxel–cholesterol complex
title_full_unstemmed Improving antitumor outcomes for palliative intratumoral injection therapy through lecithin–chitosan nanoparticles loading paclitaxel–cholesterol complex
title_sort improving antitumor outcomes for palliative intratumoral injection therapy through lecithin–chitosan nanoparticles loading paclitaxel–cholesterol complex
publisher Dove Medical Press
publishDate 2019
url https://doaj.org/article/028c8e36302d466a8f59f630d8cab24e
work_keys_str_mv AT chuxy improvingantitumoroutcomesforpalliativeintratumoralinjectiontherapythroughlecithinndashchitosannanoparticlesloadingpaclitaxelndashcholesterolcomplex
AT huangw improvingantitumoroutcomesforpalliativeintratumoralinjectiontherapythroughlecithinndashchitosannanoparticlesloadingpaclitaxelndashcholesterolcomplex
AT wangyl improvingantitumoroutcomesforpalliativeintratumoralinjectiontherapythroughlecithinndashchitosannanoparticlesloadingpaclitaxelndashcholesterolcomplex
AT menglw improvingantitumoroutcomesforpalliativeintratumoralinjectiontherapythroughlecithinndashchitosannanoparticlesloadingpaclitaxelndashcholesterolcomplex
AT chenlq improvingantitumoroutcomesforpalliativeintratumoralinjectiontherapythroughlecithinndashchitosannanoparticlesloadingpaclitaxelndashcholesterolcomplex
AT jinmj improvingantitumoroutcomesforpalliativeintratumoralinjectiontherapythroughlecithinndashchitosannanoparticlesloadingpaclitaxelndashcholesterolcomplex
AT chenl improvingantitumoroutcomesforpalliativeintratumoralinjectiontherapythroughlecithinndashchitosannanoparticlesloadingpaclitaxelndashcholesterolcomplex
AT gaoch improvingantitumoroutcomesforpalliativeintratumoralinjectiontherapythroughlecithinndashchitosannanoparticlesloadingpaclitaxelndashcholesterolcomplex
AT gec improvingantitumoroutcomesforpalliativeintratumoralinjectiontherapythroughlecithinndashchitosannanoparticlesloadingpaclitaxelndashcholesterolcomplex
AT gaozg improvingantitumoroutcomesforpalliativeintratumoralinjectiontherapythroughlecithinndashchitosannanoparticlesloadingpaclitaxelndashcholesterolcomplex
AT gaocs improvingantitumoroutcomesforpalliativeintratumoralinjectiontherapythroughlecithinndashchitosannanoparticlesloadingpaclitaxelndashcholesterolcomplex
_version_ 1718399853069860864